IRAKLI GIORGBERIDZE to Humans
This is a "connection" page, showing publications IRAKLI GIORGBERIDZE has written about Humans.
Connection Strength
0.065
-
Modified Pull-Through Technique for Cardiac Resynchronization Therapy Upgrades in Patients with Occluded Access Veins. Tex Heart Inst J. 2020 02; 47(1):23-26.
Score: 0.017
-
The Role of Electrophysiologic Study in Device Selection for Leadless Atrial Pacing. Tex Heart Inst J. 2025 Jan-Jun; 52(1):e248495.
Score: 0.006
-
Association of acute kidney injury with outcomes in patients undergoing percutaneous left atrial appendage closure. Catheter Cardiovasc Interv. 2021 11 15; 98(6):E839-E846.
Score: 0.005
-
Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trial. Heart Rhythm. 2021 07; 18(7):1045-1054.
Score: 0.005
-
Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical Trial. JAMA. 2020 10 27; 324(16):1620-1628.
Score: 0.005
-
Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study. Am J Cardiol. 1997 Sep 11; 80(5B):3F-9F.
Score: 0.004
-
Effects of high-frequency atrial pacing in atypical atrial flutter and atrial fibrillation. J Interv Card Electrophysiol. 1997 Sep; 1(2):111-23.
Score: 0.004
-
Efficacy and safety of radiofrequency catheter ablation of left-sided accessory pathways through the coronary sinus. Am J Cardiol. 1995 Aug 15; 76(5):359-65.
Score: 0.003
-
Radiofrequency catheter ablation of left-sided accessory pathways: clinical and regulatory issues in the return to the coronary venous system. J Interv Cardiol. 1995 Feb; 8(1):77-82.
Score: 0.003
-
Patient safety during radiofrequency catheter ablation: a clinical and regulatory dilemma. Pacing Clin Electrophysiol. 1994 Oct; 17(10):1577-80.
Score: 0.003
-
Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data. Int J Cardiol. 2011 Aug 04; 150(3):264-9.
Score: 0.002
-
Prospective clinical evaluation of a programmed atrial stimulation protocol for induction of sustained atrial fibrillation and flutter. J Interv Card Electrophysiol. 1999 Mar; 3(1):19-25.
Score: 0.001
-
Electrophysiology and endocardial mapping of induced atrial fibrillation in patients with spontaneous atrial fibrillation. Am J Cardiol. 1999 Jan 15; 83(2):187-93.
Score: 0.001
-
Interventional therapeutic procedures in patients with a preexisting dual site right atrial pacing system for refractory atrial fibrillation. Am J Cardiol. 1998 May 15; 81(10):1274-7.
Score: 0.001
-
The role of pacemaker therapy in the prevention of atrial fibrillation. Semin Interv Cardiol. 1997 Dec; 2(4):219-25.
Score: 0.001
-
Low-energy endocardial defibrillation using dual, triple, and quadruple electrode systems. Am J Cardiol. 1997 Jun 15; 79(12):1632-9.
Score: 0.001
-
Acute effects of dual-site right atrial pacing in patients with spontaneous and inducible atrial flutter and fibrillation. J Am Coll Cardiol. 1997 Apr; 29(5):1007-14.
Score: 0.001
-
Right and left ventricular hemodynamic performance during sustained ventricular tachycardia. Am J Cardiol. 1997 Feb 01; 79(3):323-7.
Score: 0.001
-
Evaluation of a programming algorithm for the third tachycardia zone in a fourth-generation implantable cardioverter-defibrillator. J Interv Card Electrophysiol. 1997 Feb; 1(1):49-56.
Score: 0.001
-
New generations of implantable pacemaker defibrillators for ventricular and atrial tachyarrhythmias. Arch Mal Coeur Vaiss. 1996 Feb; 89 Spec No 1:149-54.
Score: 0.001